Shed vs EnhanceMD: Flexible GLP-1 Formats vs Flat-Rate Lab-Monitored Care in 2026

Short Answer: Choose Shed for Flexibility, EnhanceMD for Price Predictability

Shed is the better fit if you want the widest GLP-1 format menu, brand-name pathway optionality, coaching, app tracking, unlimited provider appointments, free shipping, FSA eligibility, and a 10% body-weight-loss guarantee with full refund within 9 months, terms apply. Start with /go/shed if format choice and the guarantee matter most.

EnhanceMD is the cleaner choice if you want flat monthly pricing, injections only, included metabolic labs every 6 months, and lower first-month entry pricing. Use /go/enhancedmd for the main program, /go/enhancedmd-semaglutide if you already want semaglutide, or /go/enhancedmd-tirzepatide if tirzepatide is the target.

Shed vs EnhanceMD Comparison

Shed lists injections from $199/month, lozenges from $199/month, liquid drops from $229/month, and a brand-name pathway at $99/month plus pharmacy cost. PeptidePub rates Shed 4.4/5 and lists 150,000+ members plus 800,000+ collective pounds lost.

EnhanceMD lists Core semaglutide at $49 first month, then $212/month. Advanced tirzepatide is $99 first month, then $280/month. Elite is $189 first month, then $322/month. Microdosing tirzepatide is $169/month at 1 mg/week. PeptidePub rates EnhanceMD 4.3/5.

Pricing: First Month, Ongoing Cost, and Tradeoffs

EnhanceMD has the clearest listed ongoing prices. After first-month discounts, semaglutide is $212/month, tirzepatide is $280/month, and Elite is $322/month, all doses. That is the main pricing advantage: dose escalation does not change the listed monthly price.

Shed has a lower listed entry point than EnhanceMD's ongoing semaglutide price. Compounded semaglutide or tirzepatide injections start at $199/month, lozenges start at $199/month, and liquid drops start at $229/month. Buyers should confirm whether checkout pricing changes by medication, dose, format, refill cadence, coaching bundle, or brand-name pathway.

The brand-name path is the biggest variable. Shed lists a $99/month platform fee plus pharmacy cost. That $99 is not the Wegovy or Zepbound drug cost. Insurance, cash pharmacy pricing, prior authorization, and availability can change the real total.

Market context helps set expectations. HealingMaps reported that compounded GLP-1 telehealth commonly runs about $149 to $299/month in 2026, while brand-name Wegovy and Zepbound cash retail can be roughly $1,000 to $1,650/month. Vaccine Alliance reported Shed at $199 to $699/month with optional coaching, while PeptidePub lists coaching included. Treat coaching as a checkout verification item.

Medication Format and Brand-Name Access

Shed wins on format flexibility. PeptidePub lists injections, lozenges, liquid drops, oral tablets, and brand-name options. That matters for needle-averse buyers, people comparing oral-style GLP-1 access, and anyone who wants to keep a brand-name pathway open.

EnhanceMD is more focused. PeptidePub lists it as compounded injection-focused care, with no brand-name pathway, no oral format, and no lozenge format in the local review. That is not automatically worse. It is simpler if you already accept injections and mainly care about predictable pricing, labs, refills, and provider guidance.

The brand-name distinction needs to be explicit. Shed's brand-name pathway is $99/month plus pharmacy cost, so the platform fee is separate from the medication cost. Buyers should confirm insurance handling, prior authorization support, pharmacy price, and whether the actual prescription is Wegovy, Ozempic, Zepbound, Mounjaro, or a compounded product.

EnhanceMD's official homepage says prescription products require an online consultation with a healthcare professional. It also says compounded medication is not FDA-approved and that FDA has not verified safety or effectiveness. The footer says payment does not guarantee prescribing or dispensing of medication.

That is the right frame for both providers: access starts with a clinician review. A paid checkout page should not be treated as a guaranteed prescription.

Labs, Monitoring, Coaching, and Support

EnhanceMD is stronger on built-in lab monitoring. Core, Advanced, and Elite plans include metabolic lab testing every 6 months, plus baseline and ongoing lab work, provider monitoring, check-ins, dose guidance, and monthly refills. If you want lab data baked into the plan instead of treated as an add-on, EnhanceMD has the clearer structure.

Shed is stronger on behavioral support and format navigation. PeptidePub lists unlimited provider appointments, coaching included, Pivot app tracking, dose adjustments, free shipping, and FSA eligibility. That makes Shed a better fit for buyers who want more support around habits, progress tracking, and medication format choice.

The practical difference is this: EnhanceMD looks more clinical and price-standardized, while Shed looks more flexible and support-heavy. Neither model removes the need to read the checkout details.

Before paying, verify the exact lab schedule, whether labs are required before medication ships, whether lab cost is included in your state, what biomarkers are tested, and what happens if abnormal results require follow-up. For Shed, verify whether coaching is included in your specific checkout path, whether provider appointments are truly unlimited for your plan, whether dose increases affect pricing, and whether the guarantee applies to your selected medication format.

The safer buyer is the one who asks boring questions before entering payment details.

Safety and Evidence Context

Do not treat either provider's marketing as the same thing as clinical trial outcomes. The strongest evidence is for semaglutide and tirzepatide as molecules in studied protocols, not for every telehealth program, compounded vial, oral-style format, lozenge, drop, pharmacy, or individual patient.

For semaglutide, STEP 1 is the useful benchmark. It enrolled 1,961 adults with overweight or obesity without diabetes. Once-weekly semaglutide 2.4 mg plus lifestyle intervention produced 14.9% mean body-weight loss at 68 weeks, compared with 2.4% with placebo.

For tirzepatide, SURMOUNT-1 is the useful benchmark. It enrolled 2,539 adults. In the ACC summary, tirzepatide 5 mg, 10 mg, and 15 mg produced about 15.0%, 19.5%, and 20.9% body-weight reduction at 72 weeks, compared with 3.1% for placebo. At least 5% weight reduction occurred in 85.1%, 88.9%, and 90.9% of tirzepatide groups, compared with 34.5% placebo. At least 20% loss occurred in 30.0%, 50.1%, and 56.7%, compared with 3.1% placebo.

FDA's caveat is just as important. Compounded GLP-1 products are not FDA-approved finished drugs and should not be marketed as identical to approved Wegovy, Ozempic, Zepbound, or Mounjaro. Verify the prescriber, pharmacy, exact ingredient, concentration, dose instructions, refrigeration, supplies, side-effect support, cancellation rules, and refund terms.

Best Fit: Who Should Choose Shed

Choose Shed if you want the broadest medication format menu and more help staying engaged. It is the better match for buyers who dislike injections, want lozenges or liquid drops, want brand-name pathway optionality, value coaching and app tracking, or care about the 10% body-weight-loss guarantee.

Use /go/shed when the priority is flexibility plus support. The strongest Shed features in PeptidePub's review are injections from $199/month, lozenges from $199/month, liquid drops from $229/month, oral tablets, brand-name options, consultation included, free shipping, unlimited provider appointments, coaching, Pivot app tracking, dose adjustments, FSA eligibility, and the full-refund guarantee within 9 months if the 10% body-weight-loss target is not met under the terms.

The caveats are real. Shed is not necessarily the cheapest once dose, medication, format, and brand pathway are factored in. The guarantee has conditions. Format choice can be confusing. The brand-name pathway adds pharmacy cost on top of the $99/month platform fee. Public plan bundling can vary, including whether coaching is included or optional.

Before choosing Shed, verify state eligibility, guarantee terms, coaching inclusion, refill cadence, dose-related price changes, cancellation terms, pharmacy identity, pharmacy license, and what happens if the clinician does not prescribe.

Best Fit: Who Should Choose EnhanceMD

Choose EnhanceMD if you want predictable injection-focused care with flat listed prices and labs included. It is the better match if you care more about cost certainty, dose escalation without a listed price jump, monthly refills, ongoing provider support, and metabolic lab testing every 6 months than about oral formats or brand-name pathways.

Use /go/enhancedmd for the general program. Use /go/enhancedmd-semaglutide if you want semaglutide and the Core plan's $49 first month, then $212/month all doses. Use /go/enhancedmd-tirzepatide if you want tirzepatide and the Advanced plan's $99 first month, then $280/month all doses. Elite is $189 first month, then $322/month all doses for semaglutide plus tirzepatide. Microdosing tirzepatide is listed at $169/month at 1 mg/week.

The tradeoffs are clear. In PeptidePub's review, EnhanceMD is compounded only, injection-focused, less established, and does not list dedicated coaching. It also does not list a brand-name pathway. Ongoing semaglutide at $212/month and tirzepatide at $280/month are mid-range, not bargain-basement.

Before choosing EnhanceMD, confirm payment timing, state eligibility, labs, pharmacy identity, exact medication and concentration, refrigeration process, dosing instructions, refund terms if ineligible, and side-effect support.

FAQ

Which is cheaper, Shed or EnhanceMD? For semaglutide entry pricing, Shed starts at $199/month while EnhanceMD is $49 first month, then $212/month. For tirzepatide, EnhanceMD lists $99 first month, then $280/month. Shed lists compounded semaglutide or tirzepatide injections from $199/month, but buyers should verify dose and format pricing at checkout.

Which has more medication formats? Shed. PeptidePub lists injections, lozenges, liquid drops, oral tablets, and a brand-name pathway. EnhanceMD is injection-focused in PeptidePub's review.

Which includes labs? EnhanceMD lists metabolic lab testing every 6 months on Core, Advanced, and Elite. Shed's review does not list bundled labs as a main feature.

Are compounded GLP-1s FDA-approved? No. Compounded products are not FDA-approved finished drugs. Brand-name Wegovy, Ozempic, Zepbound, and Mounjaro are separate FDA-approved products when used as labeled.

Which is better for first-time buyers? Shed if format choice and support matter most. EnhanceMD if predictable pricing and lab monitoring matter most.

Bottom Line

Shed is the more flexible, feature-rich option. EnhanceMD is the more predictable, lab-monitored option. Use /go/shed for format choice, support, brand-name pathway optionality, and the 10% body-weight-loss guarantee. Use /go/enhancedmd for flat-rate care and labs, or /go/enhancedmd-semaglutide and /go/enhancedmd-tirzepatide if you already know the molecule.

Final checklist: verify state eligibility, clinician review, exact medication and format, compounded vs brand status, pharmacy identity and license, total monthly cost after promos, labs, shipping and refrigeration, dose instructions, cancellation, refund, and guarantee terms.